Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04858022 · ClinicalTrials.gov registry record · Phase 2

Visual Acoustic Biofeedback for RSE Via Telepractice

A Phase 2 study of Speech Sound Disorder, sponsored by Montclair State University.

Completed
Registry status
Phase 2
Development phase
40
Enrollment target
1
Study location

NCT04858022 is a Phase 2 study of Speech Sound Disorder that has completed, run by Montclair State University. The registered enrollment target is 40 participants, below the 87-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04858022, a Phase 2 study of Speech Sound Disorder, has completed, sponsored by Montclair State University.

COMPLETED
Registry status
Phase 2
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This research will meet a public health need by evaluating the efficacy of speech intervention supplemented with real-time visual-acoustic biofeedback when delivered using remote technologies.

Conditions Studied

Interventions

  • OTHER No Treatment
  • BEHAVIORAL Visual-Acoustic Biofeedback Treatment

Study Locations (1)

New Jersey

  • Montclair State University - Upper Montclair

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-01-15
Est. Completion 2024-04-15
Phase Phase 2

Sponsor

Montclair State University

8 total trials

What the Registry Record Tells You About NCT04858022

The ClinicalTrials.gov registry entry for NCT04858022 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 87-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (54% lower). The listed sponsor is Montclair State University, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 2 interventions - of which No Treatment is the first listed.

NCT04858022 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT04858022 about?

NCT04858022 is a clinical study titled "Visual Acoustic Biofeedback for RSE Via Telepractice". This research will meet a public health need by evaluating the efficacy of speech intervention supplemented with real-time visual-acoustic biofeedback when delivered using remote technologies.

What is the current status of trial NCT04858022?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2022-01-15. Estimated completion is 2024-04-15.

What conditions does trial NCT04858022 study?

This clinical trial studies the following conditions: Speech Sound Disorder.

What interventions are being tested in trial NCT04858022?

The interventions under investigation include: No Treatment (OTHER), Visual-Acoustic Biofeedback Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT04858022?

This trial is sponsored by Montclair State University, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04858022 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Speech Sound Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.